Hydroxy Bosentan (CAS 253688-60-7)

Hydroxy Bosentan is a chemical compound that functions as an endothelin receptor antagonist. It interacts with cellular components by specifically targeting and blocking the endothelin receptors, particularly the endothelin type A (ETA) and type B (ETB) receptors. By doing so, it disrupts the binding of endothelin, a potent vasoconstrictor, to its receptors on smooth muscle cells, leading to vasodilation. This mechanism of action ultimately results in the relaxation of blood vessels, particularly in the pulmonary vasculature, and reduces the resistance to blood flow. Additionally, Hydroxy Bosentan may act to inhibit the proliferation of smooth muscle cells, which is beneficial in conditions characterized by abnormal cell growth, such as pulmonary arterial hypertension. Furthermore, it has been observed to reduce inflammation and oxidative stress in the vasculature, contributing to its overall vasodilatory effects. In summary, Hydroxy Bosentan exerts its functional role by antagonizing endothelin receptors, leading to vasodilation, inhibition of smooth muscle cell proliferation, and reduction of inflammation and oxidative stress in the vasculature.